1-20 of 83
Authors: Samuel L Aitken
Save search
Sort by
Journal Article

Antimicrobial Stewardship and Beyond: The Many Essential Roles of Infectious Diseases Pharmacists Get access

PDF
Wesley D Kufel and others
Clinical Infectious Diseases, ciaf106, https://doi.org/10.1093/cid/ciaf106
Published: 22 April 2025
Journal Article

312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
Michael P Veve and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.102, https://doi.org/10.1093/ofid/ofae631.102
Published: 29 January 2025
Journal Article

P-639. Development of antimicrobial resistance in patients with pneumonia due to P.aeruginosa treated with cefepime or piperacillin-tazobactam

PDF
Raneem H Pallotta and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.836, https://doi.org/10.1093/ofid/ofae631.836
Published: 29 January 2025
Journal Article

311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
jason M Pogue and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.101, https://doi.org/10.1093/ofid/ofae631.101
Published: 29 January 2025
Journal Article
EDITOR'S CHOICE

A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 11, Issue 11, November 2024, ofae643, https://doi.org/10.1093/ofid/ofae643
Published: 30 October 2024
Journal Article

Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center

PDF
Frank P Tverdek and others
Open Forum Infectious Diseases, Volume 11, Issue 5, May 2024, ofae235, https://doi.org/10.1093/ofid/ofae235
Published: 25 April 2024
Journal Article

The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States—Is There a Potential Role for Durlobactam?

PDF
Samuel L Aitken and others
Clinical Infectious Diseases, Volume 79, Issue 4, 15 October 2024, Pages 834–837, https://doi.org/10.1093/cid/ciae229
Published: 25 April 2024
Journal Article

Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?

PDF
Jason M Pogue and Samuel L Aitken
Open Forum Infectious Diseases, Volume 11, Issue 1, January 2024, ofad645, https://doi.org/10.1093/ofid/ofad645
Published: 18 December 2023
Journal Article

356. Impact of CLSI Breakpoint Changes on Unit-Specific Combination Antibiograms for Gram-Negative Respiratory Isolates

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.427, https://doi.org/10.1093/ofid/ofad500.427
Published: 27 November 2023
Journal Article

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.425, https://doi.org/10.1093/ofid/ofad500.425
Published: 27 November 2023
Journal Article

1109. A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
Ryan K Shields and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.082, https://doi.org/10.1093/ofid/ofad500.082
Published: 27 November 2023
Journal Article

355. Stratification of Patient-Specific Risk Factors for Multidrug-Resistant Gram-Negative Respiratory Pathogens in Intensive Care Units (ICU)

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.426, https://doi.org/10.1093/ofid/ofad500.426
Published: 27 November 2023
Journal Article

In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam

PDF
Mollie VanNatta and others
Open Forum Infectious Diseases, Volume 10, Issue 10, October 2023, ofad504, https://doi.org/10.1093/ofid/ofad504
Published: 06 October 2023
Journal Article

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant

PDF
William C Shropshire and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 10, October 2023, Pages 2442–2450, https://doi.org/10.1093/jac/dkad249
Published: 14 August 2023
Journal Article

#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistance

PDF
Elaine Liu and others
JAC-Antimicrobial Resistance, Volume 5, Issue 4, August 2023, dlad097, https://doi.org/10.1093/jacamr/dlad097
Published: 14 August 2023
Journal Article
GUIDELINES

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

PDF
Pranita D Tamma and others
Clinical Infectious Diseases, ciad428, https://doi.org/10.1093/cid/ciad428
Published: 18 July 2023
Journal Article

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series

PDF
Madison Breeden and others
Open Forum Infectious Diseases, Volume 10, Issue 4, April 2023, ofad189, https://doi.org/10.1093/ofid/ofad189
Published: 06 April 2023
Journal Article

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA

PDF
Truc T Tran and others
JAC-Antimicrobial Resistance, Volume 5, Issue 1, February 2023, dlac131, https://doi.org/10.1093/jacamr/dlac131
Published: 02 January 2023
Journal Article

1844. Mortality associated with Stenotrophomonas maltophilia bloodstream infection in patients with leukemia

PDF
Samuel L Aitken and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1473, https://doi.org/10.1093/ofid/ofac492.1473
Published: 15 December 2022
Journal Article

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

PDF
Pranita D Tamma and others
Clinical Infectious Diseases, Volume 75, Issue 2, 15 July 2022, Pages 187–212, https://doi.org/10.1093/cid/ciac268
Published: 19 April 2022